Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #320553 on Innovation Pharmaceuticals Inc (IPIX)
Jhawker
08/25/20 2:08 PM
#320558 RE: olden_grumpini #320553
Here Today
08/25/20 2:15 PM
#320562 RE: olden_grumpini #320553
KMBJN
08/25/20 2:29 PM
#320568 RE: olden_grumpini #320553
140 3.1 Virus-induced cytopathic effect inhibition assay 151 The selectivity index (SI) for astodrimer sodium against SARS-CoV-2 ranged from 793 to 2197 152 for the initial assays where compound was added 1 hour prior to infection and 1 hour after 153 infection, respectively, and was >70 to >80 in the repeat assays, in which cytotoxicity was not 154 observed up to the highest concentration tested (0.86 mg/mL). 155 The positive control, remdesivir, was also active in the CPE inhibition assay, with a SI of >33. 156 3.2 Virucidal assay 157 A second study was performed to determine if astodrimer sodium was able to reduce viral 158 infectivity by binding to SARS-CoV-2 directly prior to infection of Vero E6 cells. Astodrimer 159 sodium treatment demonstrated a similar level of antiviral efficacy to the CPE studies (Table 1; 160 Figure 1C) with an EC50 of 1.83 µM (0.030 mg/mL) and SI of 130; n=1.